As a Senior Vice President and team lead at Lumanity, Laura Sarokin manages primary and secondary research studies that deliver market landscape analyses, product development and launch evaluations, new technology assessments, forecasting, and portfolio management. She has expertise working across a broad range of therapeutic areas in both US and global assignments that often include oncology, rare diseases, and specialized technologies, and usually involve early stages of development through Phase II.
Laura has over 30 years of experience working with pharmaceutical, biotechnology, and other healthcare companies. Laura began her career as a scientist with Pfizer (previously American Cyanamid) as Group Leader in Biotechnology research before moving into the role of Product Development Manager in Biotechnology. Laura has spent the past 20 years on the commercial consulting side, primarily at boutique consulting firms, prior to joining the company in 2021.
Laura holds a BS from Rutgers University and a PhD from Columbia University in Genetics and Development. She conducted postdoctoral research at The Rockefeller University in New York City.